TD Cowen Maintains Buy on Praxis Precision Medicine, Raises Price Target to $353

Benzinga · 1d ago
TD Cowen analyst Ritu Baral maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $251 to $353.